Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-20

Clinical Trial Update: Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome (SBS) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating teduglutide in Japanese subjects with dependence on parenteral nutrition for short bowel syndrome has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teduglutide (teduglutide)

Snippet

Sponsor: Shire | Conditions: Short Bowel Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2019-11-20